Stocks and Investing
Stocks and Investing
Mon, January 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jeffrey Hung Downgraded (CELU) to Sell and Decreased Target to $10 on, Jan 30th, 2023
Jeffrey Hung of Morgan Stanley, Downgraded "Celularity Inc." (CELU) to Sell and Decreased Target from $50 to $10 on, Jan 30th, 2023.
Jeffrey has made no other calls on CELU in the last 4 months.
There is 1 other peer that has a rating on CELU. Out of the 1 peers that are also analyzing CELU, all agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Biegler of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, December 22nd, 2022
Contributing Sources